NCT04604158Completed
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
IIT2020-13-GRESHAM-ELLY: Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Source: ClinicalTrials.gov · Last updated 21 May 2024
Brief summary (registry, in English)
This is a single-arm, prospective, interventional study in cancer survivors and patients to examine the feasibility of a mobile health application, Elly (Elly Health Inc.), to reduce levels of anxiety, stress, loneliness, and social isolation. Participants will be given access to the Elly phone application developed by Elly Health Inc. and will be asked to complete questionnaires measuring quality of life at multiple timepoints during the study.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 38 (actual)
- First submitted
- 21 Oct 2020
- Start date
- 2 Dec 2020
- Primary completion date
- 17 May 2024
- Lead sponsor
- Gillian Gresham
- Diseases
- Prostate cancer, Head and neck cancer, Kidney cancer, Bladder cancer, Melanoma, Lung cancer, Pancreatic cancer, Colorectal cancer, Multiple myeloma, Glioblastoma, Sarcoma
- NCT number
- NCT04604158
What you commit to
- Study type: Interventional
- Participants enrolled: 38
- From 2 Dec 2020 to the primary completion date, 17 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- \- Hearing loss or vision impairment that would preclude the participant from accessing and using the app (use of hearing aids or visual aids is acceptable) based on self-report.
Who the study is looking for
- Diagnosis of cancer of any type and currently receiving cancer-targeted treatment or have received cancer-targeted treatment within 6 months of consent date based on self-report. Cancer-targeted treatment includes chemotherapy, radiation therapy, hormonal therapy, biologic therapy, immunotherapy, and surgery.
- 18 years or older
- Access to and ability to use an iPhone (SE+, iOS 12.4+)
- Ability to understand and read English
- Have an understanding, ability, and willingness to fully comply with study procedures and restrictions
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cedars-Sinai Medical Center Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.